Market revenue in 2023 | USD 271.4 million |
Market revenue in 2030 | USD 545.6 million |
Growth rate | 10.5% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 56.85% in 2023. Horizon Databook has segmented the Europe deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Europe follows North America in terms of share of deep brain stimulation devices market. Presence of well-established medical centers providing deep brain stimulation therapy is a high-impact rendering driver for growth in this region.
High cost associated with conventional treatments for neurological diseases is anticipated to drive the clinical urgency for cost-effective and long-term solutions such as deep brain stimulation devices therapy.
Increasing number of patients suffering from epilepsy, PD, and depression is expected to boost the demand for deep brain stimulation devices. In addition, increase in the number of government funded research projects, such as IMPACT, to promote awareness and improve quality of patients’ lives is anticipated to fuel the growth of deep brain stimulation devices market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account